Analysis of immediate-early transcripts of equine cytomegalovirus.

This research examines the genetic structure and replication process of Equine Cytomegalovirus (ECMV), identifying and mapping eight initial immediate-early (IE) transcripts to two regions in the viral genome, each with its own unique attributes and contribution to the infection cycle.

Genetic Structure of ECMV

• Equine Cytomegalovirus (ECMV) has a linear, double-stranded DNA genome, basically composed of a unique 146-kilo base pair (kbp) region.
• This unique region is flanked by two 18-kbp direct repeat (DR) sequences customarily situated on both ends.

Dividing Viral Transcription into Phases

• Viral transcription was divided into immediate-early (IE), early, and late phases using cycloheximide, actinomycin D, and phosphonoacetic acid.
• These substances were applied to the infected cell cultures to manipulate the transcription phases.

Identification and Mapping of IE Transcripts

• Eight IE transcripts were identified and mapped onto two specific regions, namely region I and region II, of the viral genome.
• Region I yielded two IE RNAs of 13.0kb and 5.5kb sizes. These genes are diploid and are transcribed from within the DR regions.
• The other six IE transcripts (17.0, 9.0, 7.2, 6.8, 4.5, and 4.2 kb) were found to originate from region II. This region spans both unique and DR sequences and is located at the left terminus of the genome.
• Significantly, region II IE transcripts are spliced and transcribed in the opposite direction from region I IE transcripts.

Differences in IE Transcript Presence

• IE transcripts from region I were present throughout the replication cycle.
• In contrast, IE transcripts from region II were more abundant during the IE stage than in the early and late stages of infection.

Significance of the Study

• This research highlights that ECMV differs significantly from other herpesviruses in terms of its IE gene organization and the unusually large transcription units.
• The findings could potentially enhance the understanding of the ECMV virus replication process and can contribute to the development of more efficient treatment strategies.